scispace - formally typeset
J

José Carlos Bouso

Researcher at Autonomous University of Barcelona

Publications -  68
Citations -  2212

José Carlos Bouso is an academic researcher from Autonomous University of Barcelona. The author has contributed to research in topics: Ayahuasca & Medicine. The author has an hindex of 20, co-authored 51 publications receiving 1558 citations. Previous affiliations of José Carlos Bouso include Autonomous University of Madrid & Hospital de Sant Pau.

Papers
More filters
Journal ArticleDOI

Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of Ayahuasca: a longitudinal study.

TL;DR: In this article, the authors assessed personality, psychopathology, life attitudes and neuropsychological performance in regular ayahuasca users and non-users at baseline and 1 year later, and found no evidence of psychological maladjustment, mental health deterioration or cognitive impairment.
Journal ArticleDOI

Assessment of addiction severity among ritual users of ayahuasca

TL;DR: The ritual use of ayahuasca, as assessed with the ASI in currently active users, does not appear to be associated with the deleterious psychosocial effects typically caused by other drugs of abuse.
Journal ArticleDOI

Pattern of use and subjective effects of Salvia divinorum among recreational users.

TL;DR: The observed simultaneous high scores on the LSD and PCAG subscales of the Addiction Research Center Inventory (ARCI) have been previously reported for other kappa-opioid agonists, and support kappa receptor activation as the probable pharmacologic mechanism underlying the modified state of awareness induced by salvia.
Journal ArticleDOI

MDMA-Assisted Psychotherapy Using Low Doses in a Small Sample of Women with Chronic Posttraumatic Stress Disorder

TL;DR: It was found that low doses of MDMA were both psychologically and physiologically safe for all the subjects and future studies in larger samples and using larger doses are needed in order to further clarify the safety and efficacy of MDMA in the clinical setting in subjects with PTSD.